Trial Profile
An European, non-interventional, multi-database, analytical cohort post-authorization safety study of vildagliptin in patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jul 2018
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 29 Jul 2018 New trial record